skimmin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, RJ; Liang, RK; Shi, ML; Zhang, BG; Zhang, G; Zhao, YJ; Zhao, YY | 1 |
| Chen, X; Li, H; Li, Y; Liu, Y; Yang, J; Zhang, D; Zhang, F; Zhang, S; Zhou, W | 1 |
2 other study(ies) available for skimmin and Alloxan Diabetes
| Article | Year |
|---|---|
Skimmin protects diabetic cardiomyopathy in streptozotocin-induced diabetic rats.
Topics: Animals; Autophagy; Body Weight; Cardiotonic Agents; Caspase 1; Chronic Disease; Coumarins; Cytokines; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucose; Heart; Heart Rate; Inflammation; Inflammation Mediators; Interleukin-1beta; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pyroptosis; Rats, Sprague-Dawley; Streptozocin | 2021 |
Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats.
Topics: Animals; Coumarins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hypoglycemic Agents; Kidney; Male; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta1 | 2012 |